Find research datasets worth reusing
Search datasets from major research repositories and use ShareScore to quickly assess how well each record supports discovery, access, and reuse.
15,247
datasets available to search
ShareScore release 0.9.0
Dataset results
15,247 results for “Breast cancer”
Erlotinib Hydrochloride and Bevacizumab in Treating Patients With Stage IV Breast Cancer
ClinicalTrials.gov study NCT00054132. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Study of Panobinostat Monotherapy in Women With v-ERB-B2 Avian Erythroblastic Leukemia Viral Oncogene Homolog 2 (HER2) Positive Locally Recurrent or Metastatic Breast Cancer
ClinicalTrials.gov study NCT00777335. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Copper Cu 64-DOTA-Trastuzumab PET in Predicting Response to Treatment With Ado-Trastuzumab Emtansine in Patients With Metastatic HER2 Positive Breast Cancer
ClinicalTrials.gov study NCT02226276. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Study of BMS-754807 Combined With Letrozole or BMS-754807 Alone in Patients With Hormone Receptor-Positive Breast Cancer and Resistance to Non-Steroidal Aromatase Inhibitors
ClinicalTrials.gov study NCT01225172. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Carboplatin, Paclitaxel, and Bevacizumab in Treating Patients With Locally Recurrent or Metastatic Breast Cancer
ClinicalTrials.gov study NCT00654836. IPD Sharing: NO. Countries: 1. Publications: 0.
A Retrospective Study of Prognostic Factors and Survival of Breast Cancer Patients with Brain Metastesis
ClinicalTrials.gov study NCT06723132. IPD Sharing: UNDECIDED. Countries: 0. Publications: 1.
Study of a Shortened Radiation Therapy Schedule in People With Breast Cancer
ClinicalTrials.gov study NCT04648904. IPD Sharing: YES. Countries: 1. Publications: 0.
4-1BB Agonist Monoclonal Antibody PF-05082566 With Trastuzumab Emtansine or Trastuzumab in Treating Patients With Advanced HER2-Positive Breast Cancer
ClinicalTrials.gov study NCT03364348. IPD Sharing: NO. Countries: 1. Publications: 0.
Melatonin Versus Placebo in Breast Cancer
ClinicalTrials.gov study NCT01805089. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Phosphatidylinositol Glycan Anchor Biosynthesis Class U Protein in Breast Cancer
ClinicalTrials.gov study NCT07130162. IPD Sharing: Not stated. Countries: 0. Publications: 5.
Preoperative Trial of Sorafenib in Combination With Cisplatin Followed by Paclitaxel for Early Stage Breast Cancer
ClinicalTrials.gov study NCT01194869. IPD Sharing: Not stated. Countries: 1. Publications: 0.
VisR for Noninvasively Interrogating Stromal Collagen Organization as a Breast Cancer Biomarker: Evaluation of Compression in Control Subjects
ClinicalTrials.gov study NCT06547034. IPD Sharing: YES. Countries: 1. Publications: 0.
A Study of Bevacizumab With Taxane Therapy in Participants With Triple Negative Breast Cancer
ClinicalTrials.gov study NCT01094184. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Carboplatin, Nab-Paclitaxel and Pembrolizumab for Metastatic Triple-Negative Breast Cancer
ClinicalTrials.gov study NCT03121352. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Phase II Study of Curcumin vs Placebo for Chemotherapy-Treated Breast Cancer Patients Undergoing Radiotherapy
ClinicalTrials.gov study NCT01740323. IPD Sharing: NO. Countries: 1. Publications: 0.
Oral Deforolimus With Trastuzumab for Patients With HER2-positive Trastuzumab-Refractory Metastatic Breast Cancer (8669-009)
ClinicalTrials.gov study NCT00736970. IPD Sharing: Not stated. Countries: 0. Publications: 1.
Diagnostic and Prognostic Value of MicroRNA in Breast Cancer Patients
ClinicalTrials.gov study NCT04778202. IPD Sharing: Not stated. Countries: 0. Publications: 1.
A Study of AMG 706 or Bevacizumab, in Combination With Paclitaxel Chemotherapy, as Treatment for Breast Cancer
ClinicalTrials.gov study NCT00356681. IPD Sharing: Not stated. Countries: 0. Publications: 1.
Onapristone and Fulvestrant for ER+ HER2- Metastatic Breast Cancer After Endocrine Therapy and CDK4/6 Inhibitors (The SMILE Study)
ClinicalTrials.gov study NCT04738292. IPD Sharing: NO. Countries: 1. Publications: 0.
Zoledronate in Preventing Bone Loss in Postmenopausal Women Who Are Receiving Letrozole for Stage I, Stage II, or Stage IIIA Breast Cancer
ClinicalTrials.gov study NCT00107263. IPD Sharing: Not stated. Countries: 0. Publications: 2.
ScienceDex guides
Understand access before you commit
These curated guides explain access requirements, typical timelines, costs, and reuse considerations for widely used research datasets.
Allen Brain Atlas
Allen Brain Atlas is an Allen Institute collection of brain map atlases, datasets, APIs, and analysis tools covering mouse, human, and non-human primate brain resources.
Annotated Behaviour and Observability Dataset (ABODe)
ABODe is a University of Edinburgh DataShare dataset for behavior classification in group-housed mice using home-cage video, identities, bounding boxes, ground-plate positions, and annotator labels.
DANDI Archive for NWB datasets
DANDI is a BRAIN Initiative archive for publishing and sharing neurophysiology data, including electrophysiology, optophysiology, and behavioral data packaged as NWB and related standards.
International Brain Laboratory public data
The International Brain Laboratory public data releases expose standardized mouse decision-making experiments, including Neuropixels recordings, widefield calcium imaging, behavior, and session metadata accessed through the ONE API.
OpenNeuro
OpenNeuro is a free, open platform for sharing neuroimaging datasets, with public search, dataset pages, and download paths for web, S3, DataLad, and the OpenNeuro CLI.